| Literature DB >> 11572491 |
Abstract
Mineral Trioxide Aggregate (MTA) is a new material recently approved by the FDA for use in pulpal therapy. MTA has been reported to have superior biocompatibility and sealing ability and is less cytotoxic than other materials currently used in pulpal therapy. This report is a review of MTA's physical and biological properties and the clinical techniques of direct pulp capping, apexification, and repair of failed calcium hydroxide therapy.Entities:
Mesh:
Substances:
Year: 2001 PMID: 11572491
Source DB: PubMed Journal: Pediatr Dent ISSN: 0164-1263 Impact factor: 1.874